An investigation on behalf of investors in NYSE:EXAM shares in connection with the proposed takeover of Examworks Group was announced and NYSE:EXAM stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 05/03/2016 -- The takeover of Examworks Group, Inc is under investigation over potential wrongdoing. The investigation was announced for investors, who currently hold NYSE:EXAM shares, concerning whether the takeover of Examworks Group, Inc. for $35.05 per share is unfair.
Investors who purchased shares of Examworks Group, Inc. (NYSE:EXAM) and currently hold any of those NYSE:EXAM shares have certain options and should contact the Shareholders Foundation at firstname.lastname@example.org or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain officers and directors of Examworks Group, Inc. breached their fiduciary duties owed to NYSE:EXAM investors in connection with the proposed acquisition.
On April 27, 2016, Examworks Group, Inc. (NYSE:EXAM) announced today that it has entered into an agreement to be acquired by an affiliate of Leonard Green & Partners, L.P., for $35.05 per share in cash, representing a total transaction value of approximately $2.2 billion.
However, given that at least one analyst has set the high target price for NYSE:EXAM shares at $41.00 per share, the investigation concerns whether the offer is unfair to NYSE:EXAM stockholders. More specifically, the investigation concerns whether the Examworks Group Board of Directors undertook an adequate sales process, adequately shopped the company before entering into the transaction, maximized shareholder value by negotiating the best price, and acted in the shareholders' best interests in connection with the proposed sale.
Shares of Examworks Group, Inc. (NYSE:EXAM) closed on April 29, 2016, at $36.05 per share.
Those who are current investors in Examworks Group, Inc. shares have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego